您的当前位置:首页 > 行业数据 > Exhibit 7: Summary of stakeholder interview responses (n=20) to assess the relative impact of key drivers and barriers influencing biomarker testing adoption in oncology

Exhibit 7: Summary of stakeholder interview responses (n=20) to assess the relative impact of key drivers and barriers influencing biomarker testing adoption in oncology

图片属性
图片格式:PNG 图片大小:218KB 图片尺寸:2091*1171
同报告图片
 / 4
Exhibit 7: Summary of stakeholder interview responses (n=20) to assess the relative impact of key drivers and barriers influencing biomarker testing adoption in oncology_第1页
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
Exhibit 7: Summary of stakeholder interview responses (n=20) to assess the relative impact of key drivers and barriers influencing biomarker testing adoption in oncology_第2页
Exhibit 7: Summary of stakeholder interview responses (n=20) to assess the relative impact of key drivers and barriers influencing biomarker testing adoption in oncology_第3页
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
Exhibit 7: Summary of stakeholder interview responses (n=20) to assess the relative impact of key drivers and barriers influencing biomarker testing adoption in oncology_第4页
Exhibit 7: Summary of stakeholder interview responses (n=20) to assess the relative impact of key drivers and barriers influencing biomarker testing adoption in oncology_第5页
所属报告: 艾昆纬(IQVIA):2026推进精准肿瘤学:美国肿瘤生物标志物检测发展趋势研究报告(英文版)(30页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠